SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-20-002703
Filing Date
2020-04-29
Accepted
2020-04-29 16:10:02
Documents
4
Period of Report
2020-06-18
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2241501zdef14a.htm DEF 14A 282814
2 G526745.JPG g526745.jpg GRAPHIC 17474
3 G160562BGI001.GIF g160562bgi001.gif GRAPHIC 119989
4 G160562BGI002.GIF g160562bgi002.gif GRAPHIC 123317
  Complete submission text file 0001047469-20-002703.txt   643281
Mailing Address 200 BERKELEY ST. FL 19 BOSTON MA 02116
Business Address 200 BERKELEY ST. FL 19 BOSTON MA 02116 (857) 702-9600
NeuroBo Pharmaceuticals, Inc. (Filer) CIK: 0001638287 (see all company filings)

IRS No.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37809 | Film No.: 20830360
SIC: 2834 Pharmaceutical Preparations